TABLE 4 Clinical studies elucidating the use of antidiabetics against ocular conditions other than glaucoma
Acknowledgements This work was supported by the National Nature Science Foundation of China (82170830), grants from the 1.3.5 project for disciplines of excellence, West China Hospital, Sichuan University (No
Employer coverage trends The employer landscape told a more nuanced story
In December 2024, tirzepatide (Zepbound) became the first medication to receive FDA approval specifically for moderate to severe OSA in adults with obesity, based on the SURMOUNT-OSA clinical trials
Research shows the peptide stimulates expression of brain-derived neurotrophic factor (BDNF) and cyclic-AMP responsive element binding protein 1 (CREB1) by regulating melatonin synthesis and circadian gene expression
Many practitioners recommend starting with a series of treatments performed weekly or bi-weekly, followed by maintenance sessions once every month or two, depending on the results desired
